Key result
Personalizing statin therapy by stroke subtype and patient profile optimizes secondary prevention in acute ischemic stroke.
Answers are grounded in this paper and cite their sources.
A personalized approach to statin therapy following acute ischemic stroke, considering stroke subtype and patient characteristics, is recommended to optimize secondary prevention.
Statins are a cornerstone of secondary prevention following acute ischemic stroke (AIS). Widely used for their lipid-lowering effects, emerging evidence suggests the pleiotropic properties of statins provide a benefit in AIS management, including for patients with low baseline lipid levels. Established guidelines for statin therapy following AIS are inconsistent. Treatment optimization requires a personalised approach which considers stroke subtype and patient characteristics. Emerging strategies in statin care following AIS include novel drug-delivery systems improving bioavailability to the brain and combination therapies for patients with comorbid conditions or resistance to statin therapy.
No takes yet. Share an insight, caveat, or question.
Michael B. Brown (2026) conducted a review in Acute ischemic stroke. Statin therapy was evaluated. Personalized statin therapy considering stroke subtype and patient characteristics is required to optimize secondary prevention following acute ischemic stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: